{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T18:22:29Z","timestamp":1778610149206,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.exer.2019.03.023","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T19:18:50Z","timestamp":1553973530000},"page":"156-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Topical bromfenac transiently delays axotomy-induced retinal ganglion cell loss"],"prefix":"10.1016","volume":"182","author":[{"given":"Giuseppe","family":"Rovere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco M.","family":"Nadal-Nicol\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma","family":"Sobrado-Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda P.","family":"Villegas-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9216-1615","authenticated-orcid":false,"given":"Manuel","family":"Vidal-Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8566-9277","authenticated-orcid":false,"given":"Marta","family":"Agudo-Barriuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2019.03.023_bib1","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/ph3061949","article-title":"Non-Steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions","volume":"3","author":"Ajmone-Cat","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.exer.2019.03.023_bib2","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2147\/OPTH.S66638","article-title":"The ocular distribution of (14)C-labeled bromfenac ophthalmic solution 0.07% in a rabbit model","volume":"8","author":"Baklayan","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2019.03.023_bib3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/jop.2007.0082","article-title":"24-hour evaluation of the ocular distribution of (14)C-labeled bromfenac following topical instillation into the eyes of New Zealand White rabbits","volume":"24","author":"Baklayan","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2019.03.023_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tips.2009.01.002","article-title":"The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research","volume":"30","author":"Choi","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.exer.2019.03.023_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/187152710791011991","article-title":"Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease","volume":"9","author":"Cole","year":"2010","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.exer.2019.03.023_bib6","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1167\/iovs.16-19618","article-title":"Different ipsi- and contralateral glial responses to anti-VEGF and triamcinolone intravitreal injections in rats","volume":"57","author":"Di Pierdomenico","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.03.023_bib7","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1073\/pnas.95.7.3978","article-title":"Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells","volume":"95","author":"Di","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.exer.2019.03.023_bib8","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1167\/iovs.12-11207","article-title":"Effect of brain-derived neurotrophic factor on mouse axotomized retinal ganglion cells and phagocytic microglia","volume":"54","author":"Galindo-Romero","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.03.023_bib9","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1523\/JNEUROSCI.0584-17.2017","article-title":"Microglia are irrelevant for neuronal degeneration and axon regeneration after acute injury","volume":"37","author":"Hilla","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2019.03.023_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.expneurol.2004.02.002","article-title":"GDNF, Ret, GFRalpha1 and 2 in the adult rat retino-tectal system after optic nerve transection","volume":"187","author":"Lindqvist","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.exer.2019.03.023_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12974-016-0558-y","article-title":"Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways","volume":"13","author":"Mac Nair","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.exer.2019.03.023_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10792-016-0279-3","article-title":"Bromfenac ophthalmic solution 0.09 %: human aqueous humor concentration detected by high-performance liquid chromatography","volume":"37","author":"Macri","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.exer.2019.03.023_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.01.002","article-title":"BAX to basics: how the BCL2 gene family controls the death of retinal ganglion cells","volume":"57","author":"Maes","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2019.03.023_bib14","doi-asserted-by":"crossref","first-page":"16299","DOI":"10.1038\/s41598-018-34527-z","article-title":"Human Wharton's jelly mesenchymal stem cells protect axotomized rat retinal ganglion cells via secretion of anti-inflammatory and neurotrophic factors","volume":"8","author":"Millan-Rivero","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2019.03.023_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12974-017-0982-7","article-title":"Microglial dynamics after axotomy-induced retinal ganglion cell death","volume":"14","author":"Nadal-Nicolas","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2019.03.023_bib16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1167\/iovs.15-18213","article-title":"Ketorolac administration attenuates retinal ganglion cell death after axonal injury","volume":"57","author":"Nadal-Nicolas","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.03.023_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fnana.2014.00099","article-title":"Displaced retinal ganglion cells in albino and pigmented rats","volume":"8","author":"Nadal-Nicolas","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.exer.2019.03.023_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exer.2009.02.015","article-title":"Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study","volume":"89","author":"Parrilla-Reverter","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.03.023_bib19","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1167\/iovs.16-20425","article-title":"Topical treatment with bromfenac reduces retinal gliosis and inflammation after optic nerve crush","volume":"57","author":"Rovere","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.03.023_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1167\/iovs.15-17841","article-title":"Apoptotic retinal ganglion cell death after optic nerve transection or crush in mice: delayed RGC loss with BDNF or a caspase 3 inhibitor","volume":"57","author":"Sanchez-Migallon","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.03.023_bib21","first-page":"281981","article-title":"Nonsteroidal anti-inflammatory drugs for retinal disease","author":"Schoenberger","year":"2013","journal-title":"Int.J.Inflam."},{"key":"10.1016\/j.exer.2019.03.023_bib22","article-title":"In vivo pharmacokinetics of bromfenac ophthalmic solution 0.075%, bromfenac ophthalmic solution 0.07%, and nepafenac\/amfenac ophthalmic suspension 0.3% in rabbits","author":"Sheppard","year":"2018","journal-title":"Ophthalmol. Times"},{"key":"10.1016\/j.exer.2019.03.023_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fnins.2017.00235","article-title":"Shared and differential retinal responses against optic nerve injury and ocular hypertension","volume":"11","author":"Vidal-Sanz","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2019.03.023_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pbr.2015.04.008","article-title":"Retinal neurodegeneration in experimental glaucoma","volume":"220","author":"Vidal-Sanz","year":"2015","journal-title":"Prog. Brain Res."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483518308996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483518308996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:00:46Z","timestamp":1757998846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483518308996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":24,"alternative-id":["S0014483518308996"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2019.03.023","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical bromfenac transiently delays axotomy-induced retinal ganglion cell loss","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2019.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}